Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN)

  • Jul. 30, 2013, 3:10 PM
    • In a replay of what happened when the Alexion/ Roche rumors first started flying, shares of BioMarin (BMRN +3%) rally on news Alexion has hired Goldman to advise on a possible buyout offer.
    • REGN also shot higher around the time the ALXN news broke.
    | Jul. 30, 2013, 3:10 PM | 1 Comment
  • Jul. 12, 2013, 3:50 PM
    Stocks moving higher on the rumored Alexion/ Roche deal include BioMarin (BMRN +7.7%) — which is already the subject of takeout rumors — Vertex Pharmaceuticals (VRTX +3.5%), Regeneron (REGN +6.9%), and the iShares Biotech ETF (IBB +2.4%).
    | Jul. 12, 2013, 3:50 PM | Comment!
REGN vs. ETF Alternatives
Company Description
Regeneron Pharmaceuticals Inc is a fully integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
Sector: Healthcare
Industry: Biotechnology
Country: United States